Grainne M Murray
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Grainne M Murray has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Amy Rees
Innovation, IMPlementation And Clinical Translation (IIMPACT) in Health, Adelaide University , Adelaide
1 shared publication - Hannah Grace Jones
Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom
1 shared publication - Marelle K. Wilson
Innovation, IMPlementation And Clinical Translation (IIMPACT) in Health, Adelaide University , Adelaide
1 shared publication - Micah D. J. Peters
Rosemary Bryant AO Research Centre, UniSA Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia
1 shared publication - Rachel Tattersall
Sheffield Teaching Hospitals and Sheffield Children’s Hospitals NHS Foundation Trusts Paediatric & Adolescent Rheumatology Sheffield
1 shared publication - Rebecca Rachael Lee
The Centre for Epidemiology, The Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, Faculty of Biology, Medicine and Health, University of Manchester , Manchester
1 shared publication
Latest Publications
- Open Access
- 29 September 2026
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 65 (10)
Exploring the relationship between pain and markers of disease activity in juvenile idiopathic arthritis: a scoping review
Objectives: Pain is common in JIA and may be challenging to treat. Clinical observation has highlighted that pain and markers of disease activity may not align, with important implications for clinical management. This scoping review aimed to map and describe the extent, nature and findings of studies examining relationships between pain and objective or clinical disease activity markers in children and young people with JIA. Methods: Joanna Briggs Institute methodology for scoping reviews was followed and the review reported against the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews checklist reporting guideline. MEDLINE, EMBASE and Scopus were searched from inception to 12 June 2025. Studies examining the relationship between self- or proxy-reported pain and at least one objective or clinical disease activity marker in individuals with JIA aged ≤24 years were included. Data were charted capturing study characteristics, pain measures, disease activity markers, analytic methods and reported relationships. Findings were synthesized descriptively and presented in tabular, visual and narrative formats. Results: One hundred and twenty-two studies were included. Overall concordance between pain and disease activity markers was uncommon. Pain aligned more consistently with physician-assessed clinical measures and composite DAS than with blood biomarkers or imaging, although the clinical measures and composite DAS may have included subjective or pain-related components. Conclusion: Relationships between pain and markers of disease activity in JIA are complex and frequently discordant. Divergence between pain and disease activity markers should be anticipated in clinical care and interpreted in parallel rather than as interchangeable indicators.
- 29 September 2026
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 65 (10)
Open AccessExploring the relationship between pain and markers of disease activity in juvenile idiopathic arthritis: a scoping review
Objectives: Pain is common in JIA and may be challenging to treat. Clinical observation has highlighted that pain and markers of disease activity may not align, with important implications for clinical management. This scoping review aimed to map and describe the extent, nature and findings of studies examining relationships between pain and objective or clinical disease activity markers in children and young people with JIA. Methods: Joanna Briggs Institute methodology for scoping reviews was followed and the review reported against the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews checklist reporting guideline. MEDLINE, EMBASE and Scopus were searched from inception to 12 June 2025. Studies examining the relationship between self- or proxy-reported pain and at least one objective or clinical disease activity marker in individuals with JIA aged ≤24 years were included. Data were charted capturing study characteristics, pain measures, disease activity markers, analytic methods and reported relationships. Findings were synthesized descriptively and presented in tabular, visual and narrative formats. Results: One hundred and twenty-two studies were included. Overall concordance between pain and disease activity markers was uncommon. Pain aligned more consistently with physician-assessed clinical measures and composite DAS than with blood biomarkers or imaging, although the clinical measures and composite DAS may have included subjective or pain-related components. Conclusion: Relationships between pain and markers of disease activity in JIA are complex and frequently discordant. Divergence between pain and disease activity markers should be anticipated in clinical care and interpreted in parallel rather than as interchangeable indicators.